Literature DB >> 3576676

Genotypic analyses of cyclosporine-associated lymphoproliferations.

M A Nalesnik, T E Starzl, K A Porter, J Sklar, M L Cleary.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3576676      PMCID： PMC2955408          DOI： 10.1097/00007890-198704000-00032

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  6 in total

Review 1.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

2.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

3.  Lymphoma in organ transplant recipients.

Authors: 
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

4.  Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas.

Authors:  M L Cleary; J Sklar
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

5.  Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma.

Authors:  M L Cleary; J Chao; R Warnke; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

Authors:  D W Hanto; K J Gajl-Peczalska; G Frizzera; D C Arthur; H H Balfour; K McClain; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969
  6 in total
  2 in total

1.  Clonal characteristics of posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; J Locker; R Jaffe; A J Demetris; K Hartle; J A Burnham; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

2.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

Authors:  M A Nalesnik; R Jaffe; T E Starzl; A J Demetris; K Porter; J A Burnham; L Makowka; M Ho; J Locker
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.